ProQR Therapeutics Cash Flow Statement (2021-2025) | PRQR

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -14.60M-15.90M-17.17M-19.82M-19.13M-16.89M-19.99M-12.71M-10.08M-9.59M-8.05M-6.74M-8.77M-3.88M-9.57M-10.77M-11.38M-13.87M-13.19M
Share-based Compensation 1.51M1.77M2.02M2.04M1.33M0.79M1.35M-0.39M
Change in Working Capital -1.15M2.14M5.70M22.12M-4.55M0.87M3.49M-0.69M
Change in Taxes -0.01M0.06M-0.04M0.03M-0.01M-0.02M-0.07M0.20M0.05M0.04M-0.17M-0.00M0.22M-0.42M-0.02M
Other Working Capital Changes -0.28M-0.02M-0.41M-0.26M-0.65M-0.38M-0.38M
Cash from Operations -14.19M-12.02M-9.50M4.33M-22.97M-15.84M-15.49M-18.19M
Depreciation, Depletion & Amortization
Amortization 0.00M-19.14M-17.77M0.00M-15.84M0.00M0.00M0.00M0.00M0.00M-6.26M0.00M-8.32M-2.90M-9.32M0.00M-10.99M0.00M0.00M
Investing Activities
Capital Expenditures -0.04M-0.06M-0.21M-0.26M-0.27M-0.25M-0.25M1.46M
Cash from Investing Activities -0.04M-0.06M-0.21M-0.19M-0.27M-0.25M-0.25M0.02M
Financing Activities
Cash from Financing Activities 3.60M100.37M27.79M30.82M-0.61M-0.38M-44.12M14.04M
Additional items
Exchange Rate Effect 1.02M-2.10M1.61M0.94M1.51M4.51M3.42M-1.64M
Change in Cash -10.62M88.29M18.08M34.96M-23.85M-16.47M-59.86M-4.13M
Free Cash Flow -14.15M-11.95M-9.30M4.59M-22.70M-15.59M-15.24M-19.65M
Net Cash Flow -10.62M88.29M18.08M34.96M-23.85M-16.47M-59.86M-4.13M